View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

BUREAU VERITAS: Number of shares and voting rights as of October 31, 2...

BUREAU VERITAS: Number of shares and voting rights as of October 31, 2025 REGULATED INFORMATION Courbevoie, France – November 12, 2025 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas Date Number of shares (1) Number of voting rights 31/10/2025 453,916,256    Theoretical number of voting rights: 560,906,628  Number of exercisable voting rights: 550,642,862   (1) including the new shares issued in Euroclear as a result of the exercise of stock options ...

 PRESS RELEASE

BUREAU VERITAS : Nombre d'actions et de droits de vote au 31 octobre 2...

BUREAU VERITAS : Nombre d'actions et de droits de vote au 31 octobre 2025                  INFORMATION RÈGLEMENTÉE Courbevoie, France – 12 novembre 2025 Information relative au nombre d’actions et de droits de vote prévue par l’article 223-16 du règlement général de l’Autorité des marchés financiers Emetteur : Bureau Veritas Date de l’arrêté Nombre d’actions en circulation (1) Nombre total de droits de vote 31/10/2025 453 916 256   Nombre de droits de vote théoriques : 560 906 628 Nombre de droits de vote exerçables : 550 642 862   (1)   y compris les actions...

Andres Bolumburu
  • Andres Bolumburu

CELLNEX: 3Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

3Q'25 vs. 3Q'24 Results Sales: € 995.0 M (+1.3% vs. +1.2% BS(e) and +1.3% consensus); EBITDA: € 831.0 M (+2.7% vs. +2.2% BS(e) and +2.2% consensus); Net Profit: € -158.0 M (vs. € 278 M in 3Q’24); 9M'25 vs. 9M'24 Results Sales: € 2.937 Bn (+1.2% vs. +1.1% BS(e) and +1.2% consensus); EBITDA: € 2.436 Bn (+2.1% vs. +1.9% BS(e) and +1.9% consensus); Net Profit: € -263.0 M (€ -148.0 M in 9M'24 vs);

Andres Bolumburu
  • Andres Bolumburu

CELLNEX: RDOS. 9MESES’25 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'25 vs 3T'24: Ventas: 995,0 M euros (+1,3% vs +1,2% BS(e) y +1,3% consenso); EBITDA: 831,0 M euros (+2,7% vs +2,2% BS(e) y +2,2% consenso); BDI: -158,0 M euros (vs 278 M euros en 3T’24); Rdos. 9meses'25 vs 9meses'24: Ventas: 2.937 M euros (+1,2% vs +1,1% BS(e) y +1,2% consenso); EBITDA: 2.436 M euros (+2,1% vs +1,9% BS(e) y +1,9% consenso); BDI: -263,0 M euros (-148,0 M euros en 9meses'24).

Research Department
  • Research Department

IBERIAN DAILY 07 NOVEMBER + 3Q'25 RESULTS. HIGHLIGHTS AND REST OF PREV...

NEWS SUMMARY: ACS, AMADEUS, CELLNEX, IAG, SACYR. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 3Q’25 results to be released over the coming days in Spain. Doubts persist With the results campaign entering the final stretch, the main European indices closed with losses, with the IBEX standing out as the best performer, remaining at around 16,100. In the STOXX 600, Basic Mate...

Research Department
  • Research Department

INFORME DIARIO 07 NOVIEMBRE + RDOS. ESPAÑA Y EUROPA 3T’25. IDEAS DESTA...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACS, AMADEUS, CELLNEX, IAG, SACYR. EUROPA: BAYER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’25 que se publicarán en España y Europa en los próximos días. Se mantienen las dudas Con la campaña de resultados entrando en su recta final, los principales índices europeos cerraron con pérdidas, destacando...

Felix Fischer ... (+6)
  • Felix Fischer
  • Haidje Rustau
  • Jayanth Kandalam
  • Peter Low
  • Si Yong Ng
  • Trung Nguyen

Lucror Analytics - Morning Views Europe

In today's Morning Views publication we comment on developments of the following high yield issuers: Sappi, Telecom Italia, Banijay, Modulaire, Borr Drilling, Bombardier, Nissan Motor, Nomad Foods (Iglo), Ineos, Ineos Quattro, Air France-KLM, Victoria

James Ratzer
  • James Ratzer

Cellnex (Neutral, €29, +5%) Upgrade to Neutral

Cellnex has underperformed this year by 25pp vs. the EU operators and with the stock now trading below our target price, we upgrade from Reduce to Neutral.

Carole Braudeau
  • Carole Braudeau

Credit Morning 11/06/2025

Coty: Q1 earnings down sharply as expected, slightly more optimistic guidance for Q2|NIH attempts risky return to primary market|Sappi: EBITDA plummets in Q4 and the situation is unlikely to improve in the short term|Worldline presents its transformation plan and plans a capital increase of € 500m|Air Baltic: a new liquidity injection seems unavoidable|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 06/11/2025

Coty : Résultats T1 en net repli comme attendu, guidance légèrement plus optimiste pour le T2|NIH tente un retour risqué sur le marché primaire|Sappi : l’EBITDA s’effondre au T4 et la situation ne devrait pas s’arranger à court-terme|Worldline présente son plan de transformation et compte réaliser une augmentation de capital de 500 m EUR|Air Baltic: a new liquidity injection seems unavoidable|

Jan Frederik Slijkerman ... (+5)
  • Jan Frederik Slijkerman
  • Jeroen van den Broek
  • Jesse Norcross
  • Nadège Tillier
  • Timothy Rahill

Coffee, Croissants & Credit/Snam, Veolia, Engie, CTP, Vonovia, SES, BT...

Utilities: Snam posted robust 9M25 financials, Veolia 9M25 results show continued strong growth, Engie weak 9M25 results – spread tightening limited. Telecom: SES reports weak 3Q25 earnings, BT reports soft 1H26 results, Swisscom 3Q25 results look mixed, Telecom Italia reports solid 3Q25 results, KPN guides for somewhat higher leverage. Real Estate: CTP 9M25 - robust operating trends, Vonovia 9M25 - guidance confirmed

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch